1-4 of 4
Kirit M. Ardeshna, MA MDFRCP FRCPath
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Encouraging Clinical Outcomes for Lymphoma Patients Participating in Early Phase Clinical Trials in the Current Era: A Single Institution and a Global Perspective

Jenny O'Nions, MBBChir, PhD MRCP, FRCPath, Anna Cowley, MBBS, BSc, MRCP, FRCPath, Hakim-Moulay Dehbi, PhD, Dima El-Sharkawi, MBBS BSc FRCPath MD, Shirley D'Sa, MD FRCP, FRCPath, Kirit M. Ardeshna, MA MDFRCP FRCPath, Rakesh Popat, MBBS, BSc, MRCP, FRCPath, PhD, William Townsend, MD FRCPath
Journal: Blood
Blood (2018) 132 (Supplement 1): 4227.
https://doi.org/10.1182/blood-2018-99-118497
Published: 2018
Journal Articles

The iR 2 Regimen(Ibrutinib, Lenalidomide, and Rituximab) Is Active with a Manageable Safety Profile in Patients with Relapsed/Refractory Non-Germinal Center-like Diffuse Large B-Cell Lymphoma

Radhakrishnan Ramchandren, MD, Peter Johnson, MD, Nilanjan Ghosh, MD PhD, Jia Ruan, MD PhD, Kirit M. Ardeshna, MA MDFRCP FRCPath, Roderick Johnson, MD, Gregor Verhoef, MD PhD, David Cunningham, Sven de Vos, Shireen Kassam, MD, Luis Fayad, MD, John Radford, MD FRCP, Sarah Bailly, MD, Fritz Offner, MD, David Morgan, MD, Javier Munoz, MD, Jerry Ping, PhD, Melannie Co, MD BSMedTech, BSN, Jutta K. Neuenburg, MD PhD, Andre Goy, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 402.
https://doi.org/10.1182/blood-2018-99-111163
Published: 2018
Journal Articles

Autologous EBV-Specific T Cells (CMD-003): Early Results from a Multicenter, Multinational Phase 2 Trial for Treatment of EBV-Associated NK/T-Cell Lymphoma

Won Seog Kim, MD, Ph. D., Kirit M. Ardeshna, MA MDFRCP FRCPath, Yi Lin, MD PhD, Yasuhiro Oki, MD, Jia Ruan, MD PhD, Eric D. Jacobsen, MD, Dok Hyun Yoon, MD PhD, Cheolwon Suh, MD PhD, Felipe Suarez, MD PhD, Pierluigi Porcu, MD, Jonathan E Brammer, MD, John Radford, MD, Lihua E. Budde, MD PhD, Jin Seok Kim, MD PhD, Gilles Salles, MD PhD, Catherine M. Bollard, MD FRACP, FRCPA, Arnaud Jaccard, Hye Jin Kang, MD PhD, Shannon Inman, Maryann Murray, BS, Kurt C. Gunter, MD, Daniel Y. Lee, MD PhD, Cliona M. Rooney, PhD, Helen E. Heslop, MDDSc
Journal: Blood
Blood (2017) 130 (Supplement 1): 4073.
https://doi.org/10.1182/blood.V130.Suppl_1.4073.4073
Published: 2017
Journal Articles

Patient-Reported Outcomes in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab Monotherapy, Results of a Phase 2 Study

Bastian von Tresckow, Michelle A. Fanale, MD, Kirit M Ardeshna, MA MDFRCP FRCPath, Robert W. Chen, MD, Julia Meissner, MD, Franck Morschhauser, MD PhD, Craig H. Moskowitz, MD, Pier Luigi Zinzani, MD, Hilde Giezek, Arun Balakumaran, MD PhD, Monika Raut, PhD MS, Thao Vo, Pauline Brice, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2169.
https://doi.org/10.1182/blood.V130.Suppl_1.2169.2169
Published: 2017